A

AFT Pharmaceuticals Ltd
NZX:AFT

Watchlist Manager
AFT Pharmaceuticals Ltd
NZX:AFT
Watchlist
Price: 3.5 NZD -1.41% Market Closed
Market Cap: 367m NZD

Intrinsic Value

The intrinsic value of one AFT stock under the Base Case scenario is hidden NZD. Compared to the current market price of 3.5 NZD, AFT Pharmaceuticals Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

AFT Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
AFT Pharmaceuticals Ltd

Intrinsic Value History
Dive into the past to invest in the future

AFT looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if AFT is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about AFT?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is AFT valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for AFT Pharmaceuticals Ltd.

Explain Valuation
Compare AFT to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AFT?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
AFT Pharmaceuticals Ltd

Current Assets 108.3m
Cash & Short-Term Investments 11.1m
Receivables 48.6m
Other Current Assets 48.7m
Non-Current Assets 61.5m
PP&E 3.3m
Intangibles 58.2m
Current Liabilities 43.3m
Accounts Payable 33.1m
Other Current Liabilities 10.2m
Non-Current Liabilities 28.9m
Long-Term Debt 28.2m
Other Non-Current Liabilities 734k
Efficiency

Free Cash Flow Analysis
AFT Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
AFT Pharmaceuticals Ltd

Revenue
208m NZD
Cost of Revenue
-116.3m NZD
Gross Profit
91.7m NZD
Operating Expenses
-74.1m NZD
Operating Income
17.6m NZD
Other Expenses
-5.7m NZD
Net Income
12m NZD
Fundamental Scores

AFT Profitability Score
Profitability Due Diligence

AFT Pharmaceuticals Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROE
Positive 3Y Average ROIC
Healthy Gross Margin
Sustainable 3Y Average Gross Margin
hidden
Profitability
Score

AFT Pharmaceuticals Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

AFT Solvency Score
Solvency Due Diligence

AFT Pharmaceuticals Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

AFT Pharmaceuticals Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AFT Price Targets Summary
AFT Pharmaceuticals Ltd

Wall Street analysts forecast AFT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AFT is 4.28 NZD with a low forecast of 3.94 NZD and a high forecast of 4.73 NZD.

Lowest
Price Target
3.94 NZD
13% Upside
Average
Price Target
4.28 NZD
22% Upside
Highest
Price Target
4.73 NZD
35% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for AFT is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one AFT stock?

The intrinsic value of one AFT stock under the Base Case scenario is hidden NZD.

Is AFT stock undervalued or overvalued?

Compared to the current market price of 3.5 NZD, AFT Pharmaceuticals Ltd is hidden .

Back to Top